MARKET

AEMD

AEMD

Aethlon Med
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.280
-0.030
-2.29%
After Hours: 1.330 +0.05 +3.91% 18:06 04/03 EDT
OPEN
1.320
PREV CLOSE
1.310
HIGH
1.389
LOW
1.230
VOLUME
210.55K
TURNOVER
--
52 WEEK HIGH
13.74
52 WEEK LOW
0.7640
MARKET CAP
11.99M
P/E (TTM)
-0.2840
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average AEMD stock price target is 3.000 with a high estimate of 3.000 and a low estimate of 3.000.

EPS

AEMD News

More
  • Aethlon Announces Issuance of European Patent for the Hemopurifier® in Cancer
  • PR Newswire · 03/24 13:58
  • Aethlon Medical files for $25M mixed shelf
  • seekingalpha · 03/19 18:41
  • APRN, IBIO, MFA and CMO among midday movers
  • Seeking Alpha - Article · 03/18 16:47
  • 108 Biggest Movers From Yesterday
  • Benzinga · 03/11 09:34

Industry

Advanced Medical Equipment & Technology
-1.50%
Healthcare Equipment & Supplies
-1.17%

Hot Stocks

Symbol
Price
%Change

About AEMD

Aethlon Medical, Inc. is a medical device company focused on creating devices for cancer, infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities. The Company's lead product is the Aethlon Hemopurifier, which is a device that selectively targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The Aethlon Hemopurifier sheds glycoproteins to treat infectious viral pathogens. In oncology indications, the Hemopurifier targets the removal of circulating exosomes, which are released to promote cancer progression and to seed the spread of metastasis. Through its subsidiary, Exosome Sciences, Inc. (Exosome), the Company is also developing exosome-based product candidates to diagnose and monitor neurological disorders and cancer.
More

Webull offers kinds of Aethlon Medical, Inc. stock information, including NASDAQ:AEMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AEMD stock news, and many more online research tools to help you make informed decisions.